SEC Form 4 · accession 0001584759-26-000012
Oric Pharmaceuticals, Inc. · ORIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A. Heyman
Director
Period of report
Jul 6, 2026
Accepted (ET)
Jul 8, 2026 · 4:35 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001796280
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 6, 2026 | S | 300 | $12.00 | D | 212,772 | I | See footnote |
| Common Stock | holding | — | — | — | 41,800 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC.
- F2The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.